Since the low−insulin catabolic process is prominent in DKA, it may be postulated that hyperglycemia and increased plasma free fatty acid (FFA) levels may cause GLP−1 release by stimulating the intestinal−L cells. The gene discussed is GCG; the disease is Hyperglycemia.